Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytodyn Inc (OP: CYDY )

1.845 USD -0.055 (-2.89%)
Streaming Delayed Price Updated: 1:03 PM EDT, Jun 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 862,129
Open 1.930
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.900
Today's Range 1.830 - 1.930
52wk Range 1.630 - 10.01
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER ALERT: CytoDyn Inc. (CYDY) Officers and Directors Under Investigation for Possible False Statements and Insider Trading
Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of CytoDyn Inc. (OTC: CYDY) relating to possible false statements to investors and insider trading... 
From PR Newswire
Proactive news headlines including Endexx Corp, Royal Road Minerals, American Manganese and ESE Entertainment
From GlobeNewswire News Releases

Performance

YTD
-69.10%
-69.10%
1 Month
-34.11%
-34.11%
3 Month
-25.90%
-25.90%
6 Month
-43.92%
-43.92%
1 Year
-40.87%
-40.87%

More News

Read More
Trending Penny Stocks to Buy Right Now? 4 For Your Watchlist
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
CYDY Final Deadline Tomorrow: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CYDY
From GlobeNewswire News Releases
Final Deadline Approaching on May 17, 2021: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Class Action Lawsuit Deadline
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
From PR Newswire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against CytoDyn, Inc. and Encourages Investors to Contact the Firm
From Business Wire News Releases
What's Behind This Wild-Card Coronavirus Stock?
Tags Market News GILD CYDY
From Motley Fool
CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
Tags News Covid/19 Health Care
From Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)
From Business Wire News Releases
CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
Tags Benzinga General Biotech
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.